CEO Total Pay
$124K
FY2024 Summary Compensation, below median
ANGO FY2024 SEC EDGAR DEF 14A
Angiodynamics Inc CEO pay ratio
The CEO earned $124K in FY2024 against median worker pay of $124,242 · Measuring Instruments.
- State
- DE
- Filing date
- 2025-09-25
- Industry
- Measuring Instruments
- Fiscal year
- FY2024
Data updated August 2026
CEO-to-worker pay ratio
44:1
Below Average (Scale: 0–1000:1)
CEO pay
$124K
Median worker
$124,242
Latest filing FY2024. This company's newest DEF 14A on file is for FY2024, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Angiodynamics Inc reported a 44:1 CEO-to-worker pay ratio in FY2024 - at or below the Measuring Instruments median of 121:1 across 86 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Measuring Instruments companies.
- Pay ratio
- 44:1
- FY2024 disclosed
- CEO total
- $124K
- Summary Compensation Table total
- Median worker
- $124,242
- Dodd-Frank median employee
Ratio bands among Measuring Instruments peers
Exclusive CEO-to-median-worker bands across 80 complete latest-FY filings in SIC 38. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2024
A component-level pay breakdown is not reported in Angiodynamics Inc's structured SEC pay-ratio disclosure. See our methodology →
Filing-year trail · Angiodynamics Inc
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2024. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
- Latest ratio
- 44:1
- FY2024
- vs prior FY
- -1:1
- from FY2023 45:1
- CEO $ YoY
- +11%
- $124K latest
- Filings shown
- 4
- FY2021–2024
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $5.7M | - | $98,067 | 58:1 | - |
| 2022 | $3.9M | -31% | $98,443 | 40:1 | -18:1 |
| 2023 | $112K | -97% | $111,747 | 45:1 | +5:1 |
| 2024 | $124K | +11% | $124,242 | 44:1 | -1:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1275187, FY2021–2024. Adjacent-year deltas only.
Industry Comparison - Measuring Instruments
This Company's Ratio
44:1
Industry Median Ratio
121:1
Industry Median CEO Pay
$8.0M
This CEO's Pay
$124K
Companies in Industry
86
vs. Industry Median
Below
Angiodynamics Inc: MODEST · MICRO pay ratio
Angiodynamics Inc disclosed 44:1 CEO-to-worker pay and $124K CEO total in FY2024. the CEO earned 44× the median employee ($124,242) in FY2024.
Median employee $124,242 (ELITE-MED); MODEST · MICRO stamps put about 44 median-wage years per CEO year.
Pay Ratio
44:1
Below typical
What FY2024 shows for Angiodynamics Inc
Angiodynamics Inc disclosed 44:1 CEO-to-worker pay and $124K CEO total in FY2024. The structured pay-ratio disclosure reports the total without line-item components. Measuring Instruments (SIC 38) median ratio is 121:1 across 86 FY2025 filers; Angiodynamics Inc's $124K CEO total is at or below the $8.0M industry median CEO pay.
Angiodynamics Inc stamps MODEST · MICRO · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Measuring Instruments peers.
Key Data, FY2024
- Total Compensation
- $124K
- Median Employee Pay
- $124,242
- Pay Ratio
- 44:1
- Filing Date
- 2025-09-25
Company Info
- Ticker
- ANGO
- CIK
- 1275187
- Industry
- Measuring Instruments
- SIC Code
- 3841
- State
- DE
SEC EDGAR DEF 14A for CIK 1275187, FY2024. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Angiodynamics Inc disclosed 44:1 CEO-to-worker pay and $124K CEO total in FY2024.
Read with Angiodynamics Inc
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MICRO · ELITE-MED.
Bumble Inc. · MICRO
ABS(ceo_total_comp) peer at $124K (Δ $38 heavier vs Angiodynamics Inc); STEEP · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
V2X, Inc. · MICRO
ABS(ceo_total_comp) peer at $124K (Δ $226 lighter vs Angiodynamics Inc); FLOOR · PAR-MED vs this page's MODEST · MICRO · ELITE-MED.
Lsi Industries Inc · MICRO
ABS(ceo_total_comp) peer at $125K (Δ $258 heavier vs Angiodynamics Inc); FLOOR · PAR-MED vs this page's MODEST · MICRO · ELITE-MED.
Prologis, Inc. · MICRO
ABS(ceo_total_comp) peer at $124K (Δ $497 lighter vs Angiodynamics Inc); STEEP · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Measuring Instruments benchmark
Angiodynamics Inc stamps MODEST · MICRO · ELITE-MED inside SIC 38 - open the industry median board after the ABS peers.
Pay-ratio rankings · MODEST
See where MODEST · MICRO packages sit on the national leaderboard after reading Angiodynamics Inc.
Ratio primer · MODEST
Angiodynamics Inc's MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Angiodynamics Inc (CIK 1275187), FY2024. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.